Publications by authors named "Peter Classi"

Claim this Profile
I
Initial Evaluation of the Pulmonary Hypertension Functional Classification Self-Report (PH-FC-SR) Measurement Properties: A Patient-Focused Measure.
Rebecca Crawford, Lori McLeod, Stuart Yarr, Ross Morrison, Benjamin Wu, Peter Classi

Chest· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Burden of illness in patients with pulmonary hypertension due to interstitial lung disease: a real-world analysis.
Gustavo Heresi, Bonnie Dean, Benjamin Wu, Henry Lee, Margaret R Sketch, Peter Classi

BMC Pulm Med· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Burden of pulmonary hypertension due to chronic obstructive pulmonary disease: Analysis of exacerbations and healthcare resource utilization in the United States.
James R Klinger, Benjamin Wu, Kellie Morland, Peter Classi, Ryan Fiano

Respir Med· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhaled treprostinil vs iloprost: Comparison of adherence, persistence, and health care resource utilization in patients with pulmonary arterial hypertension.
Charles D Burger, Benjamin Wu, Peter Classi, Kellie Morland

J Manag Care Spec Pharm· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Considerations When Selecting Patient-Reported Outcome Measures for Assessment of Health-Related Quality of Life in Patients With Pulmonary Hypertension: A Narrative Review.
Aaron Yarlas, Stephen C Mathai, Steven D Nathan, Hilary M DuBrock, Kellie Morland, Peter Classi

Chest· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identifying Patients with Group 3 Pulmonary Hypertension Associated with COPD or ILD Using an Administrative Claims Database.
Gustavo A Heresi, Bonnie B Dean, Howard Castillo, Henry F Lee, Peter Classi

Lung· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reasons for refusing parenteral therapy: a qualitative study of patients with pulmonary arterial hypertension.
Kellie Morland, Amresh Raina, Abigail Nails, Peter Classi, Martine Etschmaier

Pulm Circ· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of the Pulmonary Hypertension Functional Classification Self-Report: a patient version adapted from the World Health Organization Functional Classification measure.
Kristin B Highland, Rebecca Crawford, Peter Classi, Ross Morrison, Lynda Doward

Health Qual Life Outcomes· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pulmonary hypertension due to interstitial lung disease or chronic obstructive pulmonary disease: a patient experience study of symptoms and their impact on quality of life.
Hilary M DuBrock, Steven D Nathan, Bryce B Reeve, Nicholas A Kolaitis, Stephen C Mathai, Peter M Classi

Pulm Circ· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Medication Adherence and Healthcare Costs Among Patients with Pulmonary Arterial Hypertension Treated with Oral Prostacyclins: A Retrospective Cohort Study.
Bonnie B Dean, Vishal Saundankar, Dana Stafkey-Mailey, Rebekah H Anguiano, Andrew C Nelsen, Peter Classi

Drugs Real World Outcomes· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Medication Adherence and Healthcare Costs Among Patients with Pulmonary Arterial Hypertension Treated with Oral Prostacyclins: A Retrospective Cohort Study.
Bonnie B Dean, Vishal Saundankar, Dana Stafkey-Mailey, Rebekah H Anguiano, Andrew C Nelsen, Peter Classi

Drugs Real World Outcomes· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibiotic Treatment Failure and Associated Outcomes Among Adult Patients With Community-Acquired Pneumonia in the Outpatient Setting: A Real-world US Insurance Claims Database Study.
Glenn Tillotson, Thomas Lodise, Peter Classi, Donna Mildvan, James A McKinnell

Open Forum Infect Dis· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Role of Noninvasive Endpoints in Predicting Long-Term Outcomes in Pulmonary Arterial Hypertension.
Samantha L Wronski, Margaret Mordin, Kim Kelley, Rebekah H Anguiano, Peter Classi

Lung· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identifying Patients with Pulmonary Arterial Hypertension Using Administrative Claims Algorithms.
Stephen C Mathai, Anna Ryan Hemnes, Scott Manaker, Rebekah H Anguiano, Bonnie B Dean, Peter Classi

Ann Am Thorac Soc· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical relevance of fatigue as a residual symptom in major depressive disorder.
Maurizio Fava, Susan Ball, J Craig Nelson, Jondavid Sparks, Thomas Konechnik, Peter Classi

Depress Anxiety· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What happens next?: a claims database study of second-line pharmacotherapy in patients with major depressive disorder (MDD) who initiate selective serotonin reuptake inhibitor (SSRI) treatment.
Susan Ball, Peter Classi, Ellen B Dennehy

Ann Gen Psychiatry· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient preferences for treatment of major depressive disorder and the impact on health outcomes: a systematic review.
Heather L Gelhorn, Chris C Sexton, Peter M Classi

Prim Care Companion CNS Disord· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The co-occurrence of reading disorder and ADHD: epidemiology, treatment, psychosocial impact, and economic burden.
Chris C Sexton, Heather L Gelhorn, Jill A Bell, Peter M Classi

J Learn Disabil· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Social and emotional difficulties in children with ADHD and the impact on school attendance and healthcare utilization.
Peter Classi, Denái Milton, Sarah Ward, Khaled Sarsour, Joseph Johnston

Child Adolesc Psychiatry Ment Health· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Methodologies used in cost-effectiveness models for evaluating treatments in major depressive disorder: a systematic review.
Evelina A Zimovetz, Sorrel E Wolowacz, Peter M Classi, Julie Birt

Cost Eff Resour Alloc· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient characteristics, comorbidities, and medication use for children with ADHD with and without a co-occurring reading disorder: A retrospective cohort study.
Peter M Classi, Trong K Le, Sarah Ward, Joseph Johnston

Child Adolesc Psychiatry Ment Health· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preferences related to attention-deficit/hyperactivity disorder and its treatment.
Kate Van Brunt, Louis S Matza, Peter M Classi, Joseph A Johnston

Patient Prefer Adherence· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic burden and comorbidities of attention-deficit/hyperactivity disorder among pediatric patients hospitalized in the United States.
Juliana Meyers, Peter Classi, Linda Wietecha, Sean Candrilli

Child Adolesc Psychiatry Ment Health· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis